Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

HLA-Identical Embryos Selected after in Vitro Fertilization and Pre-Implantation Genetic Diagnosis Combined with HLA Typing: A Promising Option for Successful Allogeneic Hematopoietic Stem Cell Transplantation for Children with Genetic or Malignant Disorders Who Lack an HLA-Matched Related or Unrelated Donor

Eugene Goussetis, MD, Panagiotis Tsirigotis, MD, Ioulia Peristeri, MD, Vassiliki Kitra, MD, Georgia Avgerinou, MD, George Vessalas, MD, Anna Paisiou, MD, Kalliopi Zisaki, MD, Ioannis Papassotiriou, PhD, Emmanuel Kanavakis, Stelios Graphakos, MD

Blood (2014) 124 (21): 2536.

https://doi.org/10.1182/blood.V124.21.2536.2536

Published: 2014

Journal Articles

Global Hematopoietic Stem Cell Transplantation (HSCT) At One Million: An Achievement Of Pioneers and Foreseeable Challenges For The Next Decade. A Report From The Worldwide Network For Blood and Marrow Transplantation (WBMT)

Blood (2013) 122 (21): 2133.

https://doi.org/10.1182/blood.V122.21.2133.2133

Published: 2013

Journal Articles

Definitions of histocompatibility typing terms

Eduardo Nunes, Helen Heslop, Marcelo Fernandez-Vina, Cynthia Taves, Dawn R. Wagenknecht, A. Bradley Eisenbrey, Gottfried Fischer, Kay Poulton, Kara Wacker, Carolyn Katovich Hurley, Harriet Noreen, Nicoletta Sacchi

Blood (2011) 118 (23): e180–e183.

https://doi.org/10.1182/blood-2011-05-353490

Published: 2011

Journal Articles

Variations In Efficiency of Donor Searches Between International Unrelated Blood and Marrow Donor Registries.

Roisin Dunwoody, BSc, Richard Szydlo, PhD, Linda Casey, John Davis, PhD, Susan LLoyd, Ian H Gabriel, MD, Katayoun Rezvani, MD, PhD, Jane F Apperley, MD

Blood (2010) 116 (21): 1524.

https://doi.org/10.1182/blood.V116.21.1524.1524

Published: 2010

Journal Articles

Cyclosporine and Methotrexate Compared with Cyclosporine and Mycophenolate Mofetil as GVHD Prevention Regimens In Allogeneic Stem-Cell Transplantation From Unrelated Donors; Relative Outcomes Are Dependant on Disease Status at Transplantation

Avichai Shimoni, MD, Avital Rand, RN, BSN, Noga Shem-Tov, MD, Izhar Hardan, MD, Yulia Volchek, MD, Ronit Yerushalmi, MD, Arnon Nagler, M.D.

Blood (2010) 116 (21): 2314.

https://doi.org/10.1182/blood.V116.21.2314.2314

Published: 2010

Journal Articles

Coincidental Gammopathies In Patients with Systemic Amyloidosis and Transthyretin Gene Mutations

James E. Hoffman, MD, Hani Hassoun, MD, Heather Landau, MD, Raymond L. Comenzo, MD

Blood (2010) 116 (21): 2948.

https://doi.org/10.1182/blood.V116.21.2948.2948

Published: 2010

Journal Articles

Outcome of Reduced Intensity Allografts in Patients Aged Over 45 Years with Acute Myeloid Leukaemia: Initial Results of the MRC AML15 Trial.

Nigel H. Russell, MD, Andrew J Howman, Keith Wheatley, DPhil, Robert K Hills, Charles Craddock, BM, DPhil, FRCP, FRCPath, Lars Kjeldsen, MD, PhD, John AL Yin, Alan K. Burnett

Blood (2009) 114 (22): 523.

https://doi.org/10.1182/blood.V114.22.523.523

Published: 2009

Journal Articles

How I treat amyloidosis

Raymond L. Comenzo

Blood (2009) 114 (15): 3147–3157.

https://doi.org/10.1182/blood-2009-04-202879

Published: 2009

Journal Articles

No Impact of Postremission Consolidation Chemotherapy Before Allogeneic Transplant in Patients with First Remission Acute Myeloid Leukemia with Intermediate or High Risk Cytogenetics.

Lisa O. Sproat, MD, MSW, Brian Bolwell, Lisa Rybicki, Matt Kalaycio, Robert Dean, Ronald Sobecks, Brad Pohlman, Steve Andresen, Shawnda Sungren, Josephine Chan, John Sweetenham, Ed Copelan

Blood (2008) 112 (11): 2164.

https://doi.org/10.1182/blood.V112.11.2164.2164

Published: 2008

Journal Articles

Donor Versus No Donor Analysis of Newly Diagnosed Myeloma Patients Included in the HOVON 50/54 Study

Henk Lokhorst, MD, PhD, Pieter Sonneveld, MD, PhD, Bronno van der Holt, PhD, Marinus van Oers, MD, PhD, Reinier Raymakers, MD, PhD, Sonja Zweegman, MD, PhD, Monique C. Minnema, MD, PhD, Mark Zijlmans, MD, PhD

Blood (2008) 112 (11): 461.

https://doi.org/10.1182/blood.V112.11.461.461

Published: 2008

Journal Articles

Disparities of Minor Histocompatibility Antigens in Unrelated Allo-HCT.

Miroslaw Markiewicz, MD, Urszula Siekiera, Jerzy Wojnar, MD,PhD, Iwona Wylezol, MD, Sebastian Giebel, MD, Monika Dzierzak, MD, Agnieszka Karolczyk, Jerzy Holowiecki, MD,PhD

Blood (2007) 110 (11): 3070.

https://doi.org/10.1182/blood.V110.11.3070.3070

Published: 2007

Journal Articles

Epitope-Specific Typing (EST) for HLA-DPB1 Matching: Proof of Principle for an Innovative Approach to Unrelated Hematopoietic Stem Cell Donor Selection.

Elisabetta Zino, BS, Luca Vago, MD, Simona Di Terlizzi, BS, Benedetta Mazzi, BS, Luigi D’ Amato, BS, Silvano Rossini, MD, Fabio Ciceri, MD, Maria G. Roncarolo, MD, Claudio Bordignon, MD, Katharina Fleischhauer, MD

Blood (2006) 108 (11): 3130.

https://doi.org/10.1182/blood.V108.11.3130.3130

Published: 2006

Journal Articles

Matching Status at Amino Acid Positions 57 and 65 of the HLA-DPB1 Beta Chain Determines Outcome in Recipients of Unrelated Donor Haematopoietic Stem Cell Transplants.

Bronwen E. Shaw, DipRCPath, Steven G.E. Marsh, PhD, Neema P. Mayor, J. Alejandro Madrigal, PhD

Blood (2004) 104 (11): 827.

https://doi.org/10.1182/blood.V104.11.827.827

Published: 2004

Journal Articles

Increased Disease Relapse in HLA-DPB1 Matched Recipients of Unrelated Donor Transplants Is Not Confined to Pairs Matched for the Other Five HLA loci.

Bronwen E. Shaw, DipRCPath, Steven G.E. Marsh, PhD, Neema P. Mayor, J. Alejandro Madrigal, PhD

Blood (2004) 104 (11): 829.

https://doi.org/10.1182/blood.V104.11.829.829

Published: 2004

NARROW

Global Hematopoietic Stem Cell Transplantation (HSCT) At One Million: An Achievement Of Pioneers and Foreseeable Challenges For The Next Decade. A Report From The Worldwide Network For Blood and Marrow Transplantation (WBMT)

Definitions of histocompatibility typing terms

Variations In Efficiency of Donor Searches Between International Unrelated Blood and Marrow Donor Registries.

Cyclosporine and Methotrexate Compared with Cyclosporine and Mycophenolate Mofetil as GVHD Prevention Regimens In Allogeneic Stem-Cell Transplantation From Unrelated Donors; Relative Outcomes Are Dependant on Disease Status at Transplantation

Coincidental Gammopathies In Patients with Systemic Amyloidosis and Transthyretin Gene Mutations

Outcome of Reduced Intensity Allografts in Patients Aged Over 45 Years with Acute Myeloid Leukaemia: Initial Results of the MRC AML15 Trial.

How I treat amyloidosis

No Impact of Postremission Consolidation Chemotherapy Before Allogeneic Transplant in Patients with First Remission Acute Myeloid Leukemia with Intermediate or High Risk Cytogenetics.

Donor Versus No Donor Analysis of Newly Diagnosed Myeloma Patients Included in the HOVON 50/54 Study

Disparities of Minor Histocompatibility Antigens in Unrelated Allo-HCT.

Epitope-Specific Typing (EST) for HLA-DPB1 Matching: Proof of Principle for an Innovative Approach to Unrelated Hematopoietic Stem Cell Donor Selection.

Matching Status at Amino Acid Positions 57 and 65 of the HLA-DPB1 Beta Chain Determines Outcome in Recipients of Unrelated Donor Haematopoietic Stem Cell Transplants.

Increased Disease Relapse in HLA-DPB1 Matched Recipients of Unrelated Donor Transplants Is Not Confined to Pairs Matched for the Other Five HLA loci.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only